NEW YORK (GenomeWeb) – Roche today announced that its cobas DPX test for parvovirus B19 and hepatitis A virus in human plasma products has received the CE mark.

The cobas DPX assay is a real-time PCR duplex assay for use on the cobas 6800 and 8800 systems that uses nucleic acid amplification testing to detect viruses in blood and plasma products.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.